Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024;19(3):196-203.
doi: 10.2174/0115748871288534240322083746.

Procalcitonin and qSOFA as a Marker of Mortality in Sepsis

Ashaq Hussain Parrey  1 , Manzoor Koka  1 , Basharat Kassana  1 , Mohd Ismail  1
Affiliations
Observational Study

Procalcitonin and qSOFA as a Marker of Mortality in Sepsis

Ashaq Hussain Parrey et al. Rev Recent Clin Trials. 2024.

Abstract

Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The qSOFA and procalcitonin are currently used for both diagnostic as well as prognostic purposes.

Objective: To explore the combined use of day one procalcitonin level and qSOFA scores for prognostication of sepsis-related mortality.

Design: This was a prospective observational study.

Participants: All patients who fulfilled the inclusion criteria for sepsis with an age of more than 16 years were enrolled in the study.

Results: In this study of 211 patients, 15 patients died (7.1%) during hospital stay. Among the 15 patients who died, the highest mortality of 29.4% was seen in patients with qSOFA of "3", qSOFA of "2" had a mortality of 12.8%, qSOFA of "1" had a mortality of 1% and qSOFA of "0" had zero mortality. In this study, procalcitonin had a statistically significant positive correlation/association with both qSOFA and mortality.

Conclusion: The qSOFA and procalcitonin at presentation to the emergency department in septic patients have a significant correlation with mortality in patients hospitalized with sepsis. Obtaining these two parameters at presentation will help in managing aggressively these patients who at presentation have higher qSOFA and procalcitonin levels.

Keywords: CRP.; PCT; Sepsis; mortality; procalcitonin; qSOFA.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Singer M.; Deutschman C.S.; Seymour C.W.; Shankar-Hari M.; Annane D.; Bauer M.; Bellomo R.; Bernard G.R.; Chiche J.D.; Coopersmith C.M.; Hotchkiss R.S.; Levy M.M.; Marshall J.C.; Martin G.S.; Opal S.M.; Rubenfeld G.D.; van der Poll T.; Vincent J.L.; Angus D.C.; The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016,315(8),801-810 - DOI - PubMed
    1. Evans L.; Rhodes A.; Alhazzani W.; Antonelli M.; Coopersmith C.M.; French C.; Machado F.R.; Mcintyre L.; Ostermann M.; Prescott H.C.; Schorr C.; Simpson S.; Wiersinga W.J.; Alshamsi F.; Angus D.C.; Arabi Y.; Azevedo L.; Beale R.; Beilman G.; Belley-Cote E.; Burry L.; Cecconi M.; Centofanti J.; Coz Yataco A.; De Waele J.; Dellinger R.P.; Doi K.; Du B.; Estenssoro E.; Ferrer R.; Gomersall C.; Hodgson C.; Møller M.H.; Iwashyna T.; Jacob S.; Kleinpell R.; Klompas M.; Koh Y.; Kumar A.; Kwizera A.; Lobo S.; Masur H.; McGloughlin S.; Mehta S.; Mehta Y.; Mer M.; Nunnally M.; Oczkowski S.; Osborn T.; Papathanassoglou E.; Perner A.; Puskarich M.; Roberts J.; Schweickert W.; Seckel M.; Sevransky J.; Sprung C.L.; Welte T.; Zimmerman J.; Levy M.; Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021,47(11),1181-1247 - DOI - PubMed
    1. Sazonov V.; Abylkassov R.; Tobylbayeva Z.; Saparov A.; Mironova O.; Poddighe D.; Case Series: Efficacy and safety of hemoadsorption With HA-330 adsorber in septic pediatric patients with cancer. Front Pediatr 2021,9,672260 - DOI - PubMed
    1. Rudd K.E.; Johnson S.C.; Agesa K.M.; Shackelford K.A.; Tsoi D.; Kievlan D.R.; Colombara D.V.; Ikuta K.S.; Kissoon N.; Finfer S.; Fleischmann-Struzek C.; Machado F.R.; Reinhart K.K.; Rowan K.; Seymour C.W.; Watson R.S.; West T.E.; Marinho F.; Hay S.I.; Lozano R.; Lopez A.D.; Angus D.C.; Murray C.J.L.; Naghavi M.; Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet 2020,395(10219),200-211 - DOI - PubMed
    1. Fleischmann-Struzek C.; Goldfarb D.M.; Schlattmann P.; Schlapbach L.J.; Reinhart K.; Kissoon N.; The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med 2018,6(3),223-230 - DOI - PubMed

Publication types